Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer

NCT00524121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: erlotinib hydrochloride
OTHER: immunohistochemistry staining method
RADIATION: radiation therapy

Sponsor

Roswell Park Cancer Institute